Literature DB >> 17558564

Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits.

Judith A Siuciak1, Sheryl A McCarthy, A N Martin, D S Chapin, J Stock, D M Nadeau, S Kantesaria, D Bryce-Pritt, S McLean.   

Abstract

RATIONALE: The structurally related neuropeptides, substance P, neurokinin A, and neurokinin B, belong to a family of molecules termed tachykinins and are widely distributed in the central and peripheral nervous systems. These peptides mediate their effects through three G protein coupled receptor subtypes, the neurokinin-1, neurokinin-2 and neurokinin-3 receptors, respectively.
OBJECTIVE: To study the physiological functions of NK3, a line of NK3 knockout mice were generated and characterized in a broad spectrum of well-established behavioral tests.
RESULTS: In several tests, including spontaneous locomotor activity, elevated plus maze, forced swim, and hot plate, wild-type and knockout mice performed similarly. However, in several cognition tests, including passive avoidance, acquisition of conditioned avoidance responding (CAR), and the Morris water maze, NK3 knockout mice displayed deficits compared to wild-type mice. Although NK3 wild-type and knockout mice performed similarly in the training phase of the passive avoidance test, knockout mice had shorter latencies to enter the dark compartment on days 3 and 4, suggesting impaired retention. In the acquisition phase of the conditioned avoidance responding assay, NK3 knockout mice acquired the CAR task at a slower rate than wild-type mice. Once the CAR test was acquired, both NK3 wild-type and knockout mice responded similarly to clozapine and risperidone, drugs which suppress responding in this test. In the Morris water maze, NK3 knockout mice showed increased latencies to find the escape platform on day 3 of training, suggesting a modest, but significant delay in acquisition compared to wild-type mice.
CONCLUSION: These studies suggest a role for NK3 in learning and memory in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558564     DOI: 10.1007/s00213-007-0828-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  62 in total

1.  Interaction of the tachykinin NK3 receptor agonist senktide with behavioral effects of cocaine in marmosets (Callithrix penicillata).

Authors:  Maria A de Souza Silva; Eldon L Mello; Christian P Müller; Gerhard Jocham; Rafael S Maior; Joseph P Huston; Carlos Tomaz; Marilia Barros
Journal:  Peptides       Date:  2006-04-18       Impact factor: 3.750

2.  Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine.

Authors:  M J Bannon; L A Brownschidle; Y Tian; C J Whitty; M S Poosch; C D'sa; C A Moody
Journal:  Brain Res       Date:  1995-10-09       Impact factor: 3.252

3.  Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study.

Authors:  D Mileusnic; J M Lee; D J Magnuson; M J Hejna; J E Krause; J B Lorens; S A Lorens
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

4.  Age and species-dependent differences in the neurokinin B system in rat and human brain.

Authors:  D Mileusnic; D J Magnuson; M J Hejna; J B Lorens; S A Lorens; J M Lee
Journal:  Neurobiol Aging       Date:  1999 Jan-Feb       Impact factor: 4.673

Review 5.  Using knockout and transgenic mice to study neurophysiology and behavior.

Authors:  M R Picciotto; K Wickman
Journal:  Physiol Rev       Date:  1998-10       Impact factor: 37.312

Review 6.  The mammalian tachykinin receptors.

Authors:  C A Maggi
Journal:  Gen Pharmacol       Date:  1995-09

7.  Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig.

Authors:  N Marco; A Thirion; G Mons; I Bougault; G Le Fur; P Soubrié; R Steinberg
Journal:  Neuropeptides       Date:  1998-10       Impact factor: 3.286

8.  Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.

Authors:  A Saigo; Y Takano; T Matsumoto; M Tran; Y Nakayama; R Saito; K Yamada; H Kamiya
Journal:  Neurosci Lett       Date:  1993-09-03       Impact factor: 3.046

9.  Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat.

Authors:  Y Q Ding; R Shigemoto; M Takada; H Ohishi; S Nakanishi; N Mizuno
Journal:  J Comp Neurol       Date:  1996-01-08       Impact factor: 3.215

Review 10.  The role of neuropeptides in learning: focus on the neurokinin substance P.

Authors:  J P Huston; R U Hasenöhrl
Journal:  Behav Brain Res       Date:  1995-01-23       Impact factor: 3.332

View more
  19 in total

1.  Tacking toward reconciliation on Tacr3/TACR3 mutations.

Authors:  Robert A Steiner; Víctor M Navarro
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

2.  TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood.

Authors:  Elena Gianetti; Cintia Tusset; Sekoni D Noel; Margaret G Au; Andrew A Dwyer; Virginia A Hughes; Ana Paula Abreu; Jessica Carroll; Ericka Trarbach; Leticia F G Silveira; Elaine M F Costa; Berenice Bilharinho de Mendonça; Margaret de Castro; Adriana Lofrano; Janet E Hall; Erol Bolu; Metin Ozata; Richard Quinton; John K Amory; Susan E Stewart; Wiebke Arlt; Trevor R Cole; William F Crowley; Ursula B Kaiser; Ana Claudia Latronico; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2010-03-23       Impact factor: 5.958

Review 3.  Kisspeptins in human reproduction-future therapeutic potential.

Authors:  Kulvinder Kochar Kaur; Gautam Allahbadia; Mandeep Singh
Journal:  J Assist Reprod Genet       Date:  2012-09-27       Impact factor: 3.412

Review 4.  Human GnRH deficiency: a unique disease model to unravel the ontogeny of GnRH neurons.

Authors:  Ravikumar Balasubramanian; Andrew Dwyer; Stephanie B Seminara; Nelly Pitteloud; Ursula B Kaiser; William F Crowley
Journal:  Neuroendocrinology       Date:  2010-07-07       Impact factor: 4.914

Review 5.  Neurokinin B and the hypothalamic regulation of reproduction.

Authors:  Naomi E Rance; Sally J Krajewski; Melinda A Smith; Marina Cholanian; Penny A Dacks
Journal:  Brain Res       Date:  2010-08-25       Impact factor: 3.252

6.  Neurokinin B acts via the neurokinin-3 receptor in the retrochiasmatic area to stimulate luteinizing hormone secretion in sheep.

Authors:  Heather J Billings; John M Connors; Stephanie N Altman; Stanley M Hileman; Ida Holaskova; Michael N Lehman; Christina J McManus; Casey C Nestor; Britni H Jacobs; Robert L Goodman
Journal:  Endocrinology       Date:  2010-06-02       Impact factor: 4.736

7.  Uncovering novel reproductive defects in neurokinin B receptor null mice: closing the gap between mice and men.

Authors:  Jasmine J Yang; Claudia S Caligioni; Yee-Ming Chan; Stephanie B Seminara
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

8.  TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction.

Authors:  A Kemal Topaloglu; Frank Reimann; Metin Guclu; Ayse Serap Yalin; L Damla Kotan; Keith M Porter; Ayse Serin; Neslihan O Mungan; Joshua R Cook; Sazi Imamoglu; N Sema Akalin; Bilgin Yuksel; Stephen O'Rahilly; Robert K Semple
Journal:  Nat Genet       Date:  2008-12-11       Impact factor: 38.330

9.  Cognitive performance in neurokinin 3 receptor knockout mice.

Authors:  R E Nordquist; M Delenclos; T M Ballard; H Savignac; M Pauly-Evers; L Ozmen; W Spooren
Journal:  Psychopharmacology (Berl)       Date:  2008-03-20       Impact factor: 4.530

10.  Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism.

Authors:  Maria A de Souza Silva; Bernd Lenz; Andrea Rotter; Teresa Biermann; Oliver Peters; Alfredo Ramirez; Frank Jessen; Wolfgang Maier; Michael Hüll; Johannes Schröder; Lutz Frölich; Stefan Teipel; Oliver Gruber; Johannes Kornhuber; Joseph P Huston; Christian P Müller; Sandra Schäble
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.